Shares of Bayer Aktiengesellschaft (ETR:BAYN - Get Free Report) shot up 1.4% during mid-day trading on Monday . The company traded as high as €19.90 ($20.95) and last traded at €19.80 ($20.84). 4,478,001 shares were traded during trading, The stock had previously closed at €19.52 ($20.55).
Bayer Aktiengesellschaft Trading Up 0.6 %
The company has a 50-day moving average price of €25.80 and a two-hundred day moving average price of €26.78. The stock has a market cap of $19.58 billion, a P/E ratio of -15.45, a P/E/G ratio of 36.39 and a beta of 0.97. The company has a current ratio of 1.27, a quick ratio of 0.72 and a debt-to-equity ratio of 129.94.
About Bayer Aktiengesellschaft
(
Get Free Report)
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Further Reading
Before you consider Bayer Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bayer Aktiengesellschaft wasn't on the list.
While Bayer Aktiengesellschaft currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
